| Audit Committee | Position |
|---|---|
|
Mr. Homer, board member of Gemini Trust Company and managing member of venture capital firm The Venture Dept. has joined the Board and brings his extensive digital assets and regulatory experience to help navigate the evolving digital asset landscape. |
Chair
|
|
Mr. Read, former CEO & Chairman of Pfizer, has joined the Board and brings 40 years of senior management and corporate governance experience to help build an institutionally disciplined approach to the bitcoin treasury strategy. |
Member
|
|
Mr. Foster joined our board of directors in June 2021. Mr. Foster has served as the chief financial officer and executive vice president for Moleculin Biotech, Inc. since August 2016. Mr. Foster brings more than 30 years of financial experience, holding a variety of executive and senior financial positions with public and private companies, ranging from start-up to large corporate and international companies. |
Member
|
|
Audit Committee Charter |
Download |
| Compensation Committee | Position |
|---|---|
|
Mr. Foster joined our board of directors in June 2021. Mr. Foster has served as the chief financial officer and executive vice president for Moleculin Biotech, Inc. since August 2016. Mr. Foster brings more than 30 years of financial experience, holding a variety of executive and senior financial positions with public and private companies, ranging from start-up to large corporate and international companies. |
Chair
|
|
Mr. Homer, board member of Gemini Trust Company and managing member of venture capital firm The Venture Dept. has joined the Board and brings his extensive digital assets and regulatory experience to help navigate the evolving digital asset landscape. |
Member
|
|
Mr. Read, former CEO & Chairman of Pfizer, has joined the Board and brings 40 years of senior management and corporate governance experience to help build an institutionally disciplined approach to the bitcoin treasury strategy. |
Member
|
|
Compensation Committee Charter |
Download |
| Governance Committee | Position |
|---|---|
|
Mr. Read, former CEO & Chairman of Pfizer, has joined the Board and brings 40 years of senior management and corporate governance experience to help build an institutionally disciplined approach to the bitcoin treasury strategy. |
Chair
|
|
Mr. Homer, board member of Gemini Trust Company and managing member of venture capital firm The Venture Dept. has joined the Board and brings his extensive digital assets and regulatory experience to help navigate the evolving digital asset landscape. |
Member
|
|
Mr. Foster joined our board of directors in June 2021. Mr. Foster has served as the chief financial officer and executive vice president for Moleculin Biotech, Inc. since August 2016. Mr. Foster brings more than 30 years of financial experience, holding a variety of executive and senior financial positions with public and private companies, ranging from start-up to large corporate and international companies. |
Member
|
|
Governance Committee Charter |
Download |
Matthew Homer
Mr. Homer, board member of Gemini Trust Company and managing member of venture capital firm The Venture Dept. has joined the Board and brings his extensive digital assets and regulatory experience to help navigate the evolving digital asset landscape.
Ian Read
Mr. Read, former CEO & Chairman of Pfizer, has joined the Board and brings 40 years of senior management and corporate governance experience to help build an institutionally disciplined approach to the bitcoin treasury strategy.
Jonathan Foster
Mr. Foster joined our board of directors in June 2021. Mr. Foster has served as the chief financial officer and executive vice president for Moleculin Biotech, Inc. since August 2016. Mr. Foster brings more than 30 years of financial experience, holding a variety of executive and senior financial positions with public and private companies, ranging from start-up to large corporate and international companies.
Jonathan Foster
Mr. Foster joined our board of directors in June 2021. Mr. Foster has served as the chief financial officer and executive vice president for Moleculin Biotech, Inc. since August 2016. Mr. Foster brings more than 30 years of financial experience, holding a variety of executive and senior financial positions with public and private companies, ranging from start-up to large corporate and international companies.
Matthew Homer
Mr. Homer, board member of Gemini Trust Company and managing member of venture capital firm The Venture Dept. has joined the Board and brings his extensive digital assets and regulatory experience to help navigate the evolving digital asset landscape.
Ian Read
Mr. Read, former CEO & Chairman of Pfizer, has joined the Board and brings 40 years of senior management and corporate governance experience to help build an institutionally disciplined approach to the bitcoin treasury strategy.
Ian Read
Mr. Read, former CEO & Chairman of Pfizer, has joined the Board and brings 40 years of senior management and corporate governance experience to help build an institutionally disciplined approach to the bitcoin treasury strategy.
Matthew Homer
Mr. Homer, board member of Gemini Trust Company and managing member of venture capital firm The Venture Dept. has joined the Board and brings his extensive digital assets and regulatory experience to help navigate the evolving digital asset landscape.
Jonathan Foster
Mr. Foster joined our board of directors in June 2021. Mr. Foster has served as the chief financial officer and executive vice president for Moleculin Biotech, Inc. since August 2016. Mr. Foster brings more than 30 years of financial experience, holding a variety of executive and senior financial positions with public and private companies, ranging from start-up to large corporate and international companies.